gold has been researched along with Liver Steatosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelhalim, MA; Al-Ayed, MS; Al-Harbi, LN; Alshammari, GM; Yahya, MA | 1 |
| Ding, Y; He, J; Hu, Y; Huo, D; Li, H; Liu, S; Pan, CC; Zhao, HY; Zhou, ZY | 1 |
| DETER, RL; LIEBELT, RA | 1 |
1 review(s) available for gold and Liver Steatosis
| Article | Year |
|---|---|
GOLDTHIOGLUCOSE AS AN EXPERIMENTAL TOOL.
Topics: Carcinogens; Fatty Liver; Gold; Hypothalamus; Kidney Diseases; Obesity; Pancreas; Pathology; Peptic Ulcer; Research; Toxicology | 1964 |
2 other study(ies) available for gold and Liver Steatosis
| Article | Year |
|---|---|
Concomitant Sub-Chronic Administration of Small-Size Gold Nanoparticles Aggravates Doxorubicin-Induced Liver Oxidative and Inflammatory Damage, Hyperlipidemia, and Hepatic Steatosis.
Topics: Animals; Doxorubicin; Fatty Liver; Gold; Hyperlipidemias; Liver; Male; Metal Nanoparticles; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Rats; Rats, Wistar | 2023 |
Synthesis and application of strawberry-like Fe3O4-Au nanoparticles as CT-MR dual-modality contrast agents in accurate detection of the progressive liver disease.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Contrast Media; Disease Progression; Fatty Liver; Ferrosoferric Oxide; Gold; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Metal Nanoparticles; Mice, Inbred BALB C; Molecular Imaging; Multimodal Imaging; Organ Specificity; Rats, Wistar; Tomography, X-Ray Computed | 2015 |